Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

In patients with type 2 diabetes and albuminuria, dapagliflozin leads to a significant reduction in urine ...

Safeguards Of Dapagliflozin's Half Billion USD Sales In China: Astrazeneca. Legal News and Analysis - China - Conventus Law ...

AZ’s ZENITH-CKD study looked at the combination of its SGLT2 drug dapagliflozin with zibotentan, an endothelin A (ETA) receptor antagonist, on levels of albumin in the urine (albuminuria), a ...

Dapagliflozin was the first in this class whose patent expired in 2020. Leading domestic pharmaceutical companies like Mankind Pharma, Torrent, Alkem, Dr Reddy’s, and Lupin are expected to ...

Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!

Medscape Medical News, March 27, 2025 How T2D Patients With Albuminuria Respond to Dapagliflozin? In patients with type 2 diabetes and albuminuria, dapagliflozin leads to a significant reduction ...

New research has investigated how a combination of dapagliflozin and moderate calorie restriction can cause remission in Type ...